⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4555812 | 0.82 | — | — | |
| SCHEMBL37555 | 0.68 | — | — | |
| SCHEMBL828613 | 0.65 | HRH4 (0.34) | — | |
| SCHEMBL1650443 | 0.64 | HRH4 (0.37) | — | |
| SCHEMBL37603 | 0.64 | — | — | |
| SCHEMBL8069472 | 0.63 | — | — | |
| SCHEMBL168474 | 0.63 | — | — | |
| SCHEMBL8690349 | 0.63 | — | — | |
| SCHEMBL2361898 | 0.61 | — | — | |
| SCHEMBL1586586 | 0.61 | KDM1A (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13121 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4337220-A1 | SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS | Saint Joseph's University (US) | 2024-03-20 | — | — | EP | claimed |
| EP-4232425-A1 | CTPS1 INHIBITORS AND USES THEREOF | Nimbus Clotho, Inc. (US) | 2023-08-30 | — | — | EP | claimed |
| CN-116601131-A | CTPS1 inhibitor and application thereof | 林伯士克洛索有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-115819413-A | Carbazole-based small-molecule compound, method and organic all-optical synapse based on illumination history-dependent fluorescence intensity mechanism | 中国科学院大学 | 2023-03-21 | — | — | CN | claimed |
| CN-114763312-A | Method for inducing H halogenation in C-H on benzene ring or heterocyclic ring by ultraviolet light | 中国科学院大连化学物理研究所 | 2022-07-19 | — | — | CN | claimed |
| WO-2022087634-A1 | CTPS1 INHIBITORS AND USES THEREOF | NIMBUS CLOTHO, INC. (US) | 2022-04-28 | — | — | WO | claimed |
| CN-108368087-B | 2, 4-dihydroxy-nicotinamide as APJ agonists | 百时美施贵宝公司 | 2022-04-12 | — | — | CN | claimed |
| CN-113683616-A | KRAS G12C mutein inhibitors | 广州百霆医药科技有限公司 | 2021-11-23 | — | — | CN | claimed |
| CN-108602813-B | Heteroaryl hydroxypyrimidinones as APJ receptor agonists | 百时美施贵宝公司 | 2021-10-29 | — | — | CN | claimed |
| CN-113527300-A | Bruton's tyrosine protein kinase inhibitor | 广州百霆医药科技有限公司 | 2021-10-22 | — | — | CN | claimed |
| WO-2000047553-A2 | ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa | COR THERAPEUTICS INC. (US) | 2000-08-17 | — | — | WO | claimed |
| EP-0759917-B1 | NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES | GILEAD SCIENCES INC (US) | 2000-04-12 | — | — | EP | claimed |
| EP-0723533-A1 | 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-07-31 | — | — | EP | claimed |
| EP-0665215-A1 | 1,4-Diamino-2,3-dihydroxybutanes | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-08-02 | — | — | EP | claimed |
| US-5430155-A | Viricides, treatment of AIDS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-07-04 | — | — | US | claimed |
| WO-1995010506-A1 | 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-04-20 | — | — | WO | claimed |
| US-5321023-A | Pyridoindolobenzodiazepines and derivatives as antipsychotics | THE DU PONT MERCK PHARMACEUTICAL CO. (US) | 1994-06-14 | — | — | US | claimed |
| EP-0532693-A1 | 1,4-DIAMINO-2,3-DIHYDROXYBUTANES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-03-24 | — | — | EP | claimed |
| WO-1991018866-A2 | 1,4-DIAMINO-2,3-DIHYDROXYBUTANES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-12-12 | — | — | WO | claimed |
| US-4604380-A | ADMINISTERING TO TREAT BACTERIAL OR MYCOPLASMAL INFECTION | ELI LILLY AND COMPANY (US) | 1986-08-05 | — | — | US | claimed |